These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23298964)

  • 41. Cholesteryl ester transfer protein inhibition: effect on reverse cholesterol transport?
    Rensen PC; Havekes LM
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):681-4. PubMed ID: 16556861
    [No Abstract]   [Full Text] [Related]  

  • 42. Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.
    Sanders S; Geraci SA
    J Miss State Med Assoc; 2010 Mar; 51(3):75-80. PubMed ID: 20827876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unresolved issue: should patients with RA and a history of malignancy receive anti-TNF therapy?
    Brar A; Hiebert T; El-Gabalawy H
    Nat Clin Pract Rheumatol; 2007 Mar; 3(3):120-1. PubMed ID: 17334334
    [No Abstract]   [Full Text] [Related]  

  • 44. Anti-inflammatory drugs and tumor necrosis factor-alpha production from monocytes: role of transcription factor NF-kappa B and implication for rheumatoid arthritis therapy.
    Lavagno L; Gunella G; Bardelli C; Spina S; Fresu LG; Viano I; Brunelleschi S
    Eur J Pharmacol; 2004 Oct; 501(1-3):199-208. PubMed ID: 15464079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis.
    Al-Aly Z; Pan H; Zeringue A; Xian H; McDonald JR; El-Achkar TM; Eisen S
    Transl Res; 2011 Jan; 157(1):10-8. PubMed ID: 21146146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms for modulating TNF alpha in immune and inflammatory disease.
    Baugh JA; Bucala R
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):635-50. PubMed ID: 12825458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy.
    Winthrop KL; Furst DE
    Ann Rheum Dis; 2010 Oct; 69(10):1735-7. PubMed ID: 20858622
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Verhoeven AC; Boers M
    Ned Tijdschr Geneeskd; 2001 Nov; 145(47):2294-5. PubMed ID: 11760611
    [No Abstract]   [Full Text] [Related]  

  • 49. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
    Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
    Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer.
    Symmons DP; Silman AJ
    Arthritis Rheum; 2004 Jun; 50(6):1703-6. PubMed ID: 15188344
    [No Abstract]   [Full Text] [Related]  

  • 51. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Haque S; Mirjafari H; Bruce IN
    Curr Opin Lipidol; 2008 Aug; 19(4):338-43. PubMed ID: 18607179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
    Wolfe F; Caplan L; Michaud K
    Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Rheumatoid arthritis--possible risk marker of cardiovascular disease].
    Jonsson SW; Dahlqvist SR
    Lakartidningen; 2004 Nov; 101(46):3672, 3674-5. PubMed ID: 15586491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Dentener MA; Wouters EF
    N Engl J Med; 2006 Nov; 355(19):2047-8; author reply 2048. PubMed ID: 17099951
    [No Abstract]   [Full Text] [Related]  

  • 55. Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes.
    Boyer JF; Balard P; Authier H; Faucon B; Bernad J; Mazières B; Davignon JL; Cantagrel A; Pipy B; Constantin A
    Arthritis Res Ther; 2007; 9(2):R22. PubMed ID: 17335569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis.
    Marino F; Nucera V; Gerratana E; Fiorenza A; Sangari D; Miceli G; Masala IF; Atzeni F
    Pharmacol Res; 2020 Aug; 158():104507. PubMed ID: 31678639
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute-phase reactants in infections and inflammatory diseases.
    Ebersole JL; Cappelli D
    Periodontol 2000; 2000 Jun; 23():19-49. PubMed ID: 11276764
    [No Abstract]   [Full Text] [Related]  

  • 58. Rhodococcus equi infection in a patient with Crohn's disease treated with infliximab.
    Guerrero C; Tort J; Pérez J; Andrés M; Espejo E
    J Infect; 2015 Jun; 70(6):689-90. PubMed ID: 25546345
    [No Abstract]   [Full Text] [Related]  

  • 59. Mapping the immunological homunculus.
    Diamond B; Tracey KJ
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3461-2. PubMed ID: 21368214
    [No Abstract]   [Full Text] [Related]  

  • 60. Common errors in the treatment of rheumatoid arthritis.
    Moller PW
    Drugs; 1981 Apr; 21(4):297-301. PubMed ID: 7227220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.